With 97685.0 shares changed hands, the volume of the stock remained lighter than its average volume of 0.25 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $16.43 whereas the lowest price it dropped to was $15.9801. The 52-week range on ARDT shows that it touched its highest point at $20.72 and its lowest point at $14.57 during that stretch. It currently has a 1-year price target of $22.15.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ARDT was down-trending over the past week, with a drop of -3.81%, but this was down by -1.32% over a month.
Float and Shares Shorts:
At present, 142.74 million ARDT shares are outstanding with a float of 22.88 million shares on hand for trading. On 2024-12-13, short shares totaled 1.22 million, which was 86.0 higher than short shares on 1731628800. In addition to Mr. Martin J. Bonick FACHE, M.H.A. as the firm’s President, CEO & Director, Mr. Alfred Lumsdaine CPA serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.71796995 of ARDT’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, ARDT reported revenue of $1449817000.0 and operating income of $70379000.0. The EBITDA in the recently reported quarter was $109957000.0 and diluted EPS was $0.19.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With ARDT analysts setting a high price target of 25.0 and a low target of 19.0, the average target price over the next 12 months is 22.15. Based on these targets, ARDT could surge 52.16% to reach the target high and rise by 15.64% to reach the target low. Reaching the average price target will result in a growth of 34.81% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $1.31 being high and $1.06 being low. For ARDT, this leads to a yearly average estimate of $1.23.
